ASH 2022 Conference Coverage
ASH 2022 Patient Reports Outcomes & Health-Related Quality of Life From the OUTREACH Study: Lisocabtagene Maraleucel in Patients With R/R LBCL Treated as Outpatients/Inpatients in the Community/Non-University Setting
By
ASH 2022 Conference Coverage
FEATURING
Yuliya Linhares
By
ASH 2022 Conference Coverage
FEATURING
Yuliya Linhares
Login to view comments.
Click here to Login